Freshly Printed - allow 10 days lead
Couldn't load pickup availability
Coronaviruses and other Novel Antiviral Targets
Edited by one of the best scientists, this series presents the latest updates in the field of medicinal chemistry
Katherine Seley-Radtke (Volume editor)
9780323915113, Elsevier Science
Hardback, published 18 November 2021
254 pages
22.9 x 15.2 x 2.1 cm, 0.54 kg
Annual Reports in Medicinal Chemistry, Volume 57 in this long-running series, highlights new advances in the field with this new volume presenting interesting chapters on the Mechanism of action of the broadly acting antiviral drug remdesivir, Improving properties of the nucleobase analogue T-706 as a potential anti-SARS-CoV-2 and anti-influenza compound, Antivirals for RNA virus infections Anno 2020-2021, Broad spectrum antiviral fleximer nucleosides, SARS-CoV-2 main protease inhibitors, The search for antivirals to treat alphavirus infections, Inhibitors of Ebola Virus targeting Innate immune evasion, Uracil derivatives as non-nucleoside inhibitors of viral infections, and more.
1. Improving properties of the nucleobase analogs T-705/T-1105 as potential antivirals 2. Anno 2021: Which antivirals for the coming decade? 3. Broad spectrum antiviral fleximer nucleosides 4. The search for antivirals to treat alphavirus infections 5. Inhibitors of Ebola Virus targeting Innate immune evasion 6. Uracil derivatives as non-nucleoside inhibitors of viral infections
